Solugen Stock
Solugen has developed a unique process for the synthesis of hydrogen peroxide inspired by principles of cancer biology.
About Solugen Stock
Solugen has developed a unique process for the synthesis of hydrogen peroxide inspired by principles of cancer biology. This technology is used for semiconductor & electronics fabrication, water purification, aseptic packaging, precious metals mining, food & feed production, textiles & pulp bleaching, biocide disinfectants, plastics production, various chemical syntheses and rocket propulsion. Currently, hydrogen peroxide is only available through a capital intensive, environmentally dangerous process that is prone to combustion and is working at the upper limits of EPA regulations. The Solugen process uses biodegradable and extremely cheap reagents that will safely replace the current production method, saving billions of dollars in costs and significantly decreasing CO2 emissions.
Funding History
| March 2017 | $0 |
|---|---|
| September 2017 | $0 |
| October 2017 | $4.4M |
| October 2018 | $18.8M |
| March 2019 | $13.5M |
Management
Co-founder & CTO
Sean Hunt
Co-founder & CEO
Gaurab Chakrabarti
Press
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Solugen or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
